Global Coagulation Factor IX Market Projections Highlighting Primary Trends Until 2026
Coagulation factor IX isn't made by the body of hemophilia B patient thereby, external injection of coagulation factor IX is necessary for the treatment of such disorder. Coagulation factor IX is always injected directly into a vein. Lack of treatment options for hemophilia B disorder have further increased adoption of coagulation factor IX. This has brought number of opportunities for new entrants to enter in Coagulation Factor IX Market.
View full press release